查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1876452

全球干眼症治疗设备市场 - 行业分析、规模、占有率、成长、趋势和预测（2025-2032 年） - 依类型、病因、应用、最终用户和地区划分

Dry Eye Disease Treatment Devices Market - Global Dry Eye Disease Treatment Devices Industry Analysis, Size, Share, Growth, Trends, and Forecast 2025-2032 - (By Type, By Cause, By Application,By End Users, By Geographic Coverage and By Company)
出版日期: | 出版商: Fairfield Market Research | 英文 193 Pages | 商品交期: 2-5个工作天内

价格
简介目录

随着干眼症负担在各个年龄层和地区持续加重，全球干眼症治疗设备市场呈现强劲成长动能。萤幕依赖性的增加、生活方式的改变以及人们对眼部健康的日益重视，正在迅速推动对先进治疗技术的需求。预计到 2025 年，该市场规模将达到 2.6 亿美元，到 2032 年将达到 4.3 亿美元，复合年增长率 (CAGR) 为 7.5%。从传统治疗方法转向基于设备的治疗，正在增强该行业的长期成长前景。

市场洞察

干眼症 (DED) 已成为全球最常见的眼科疾病之一，严重影响患者的生活品质和视觉功能。随着临床医生寻求更有效的治疗方法，基于设备的疗法因其非侵入性、快速缓解症状以及能够解决潜在的腺体功能障碍（而不仅仅是治疗症状）而备受关注。

热脉衝疗法、标靶光疗、自动化睑板腺治疗和家用维护设备等技术进步不断重塑治疗体系。日益增强的公众意识宣传活动以及患者对高端治疗方案日益增长的需求，进一步推动了市场成长。製造商正致力于人体工学设计、便携性和提高治疗效率，以满足不断增长的临床和家庭需求。

市场推动因素

数位装置使用量的快速成长，尤其是在年轻一代中，是导致干眼症病例增加的主要因素之一。以电脑为中心的工作场所的兴起、智慧型手机依赖性的增强以及长时间的萤幕暴露，都会导致眨眼异常和泪膜不稳定。年龄增长、环境因素、配戴隐形眼镜、术后干眼、药物相关症状等因素共同作用，导致疾病的盛行率持续上升。

创新技术是主要推动力，现代医疗器材能够针对睑板腺阻塞和泪液引流通道提供标靶治疗。诊断能力的提升使得早期发现和治疗机会更加广泛。医疗保健成本的上涨、患者意识的增强以及临床对整合技术解决方案日益增长的偏好，都支撑着持续的需求。监管审批的便利性和产品的广泛普及也促进了市场扩张。

商机

全球市场在临床和居家照护方面都蕴藏着巨大的商机。尤其是在已开发市场，患者越来越追求长期舒适，同时尽可能减少就诊次数，这使得便于日常维护的紧凑型、易于使用的设备越来越受欢迎。专注于研发结合热疗、振动和机械刺激的成本效益型混合治疗系统的公司预计将吸引大量关注。

远端验光、人工智慧驱动的眼科诊断以及与智慧监测平台的整合，为未来的成长提供了强劲的潜力。製造商与大型眼科诊所连锁机构之间的合作，提高了分销效率，并提升了品牌知名度。此外，随着医疗保健可近性的提高，新兴市场的渗透率不断扩大，眼科设备的普及应用也因此成为一条充满希望​​的成长路径。

区域分析

北美在全球干眼症治疗设备市场中占主要占有率，这主要得益于人们对干眼症的广泛认知、先进治疗设备的高普及率以及日益严重的数码眼疲劳。该地区拥有强大的眼科诊所网络、强大的购买力以及持续的技术创新。

欧洲市场持续稳定成长，这主要得益于人口老化、专业医疗服务覆盖范围的扩大以及对非侵入性治疗日益增长的偏好。监管机构对先进医疗器材的支援以及对高品质眼科技术的强劲需求，都促进了该地区市场的扩张。

预计亚太地区将在预测期内成为成长最快的区域市场。快速的城市化、长时间的萤幕使用以及隐形眼镜的高使用率是干眼症盛行率上升的关键因素。中国、印度、日本和韩国等国家正在迅速扩大其眼科医疗基础设施，这为设备製造商创造了巨大的机会。

拉丁美洲和中东/非洲地区由于医疗保健服务的改善、私立医院网络的扩张以及人们对眼健康和预防性护理技术的日益重视，展现出不断增长的增长潜力。

主要公司

  • 爱尔康视觉有限公司 (Alcon Vision LLC)
  • 强生服务公司 (Johnson and Johnson Services Inc)
  • 艾伯维公司 (AbbVie Inc.)
  • Lumenis Be Ltd
  • ESW - Vision
  • MiBo Medical Group
  • Sight Sciences
  • Eyedetec Medical Inc.
  • BlephEx
  • NuSight Medicals- NuLids LLC
  • 其他

全球干眼治疗设备市场区隔

依类型

  • 睑板腺疏通装置
  • 泪小点阻塞装置
  • 止痛装置
  • 其他

依病因

  • 特发性
  • 罕见疾病
  • 手术
  • 药物相关
  • 数位暴露
  • 衰老

依应用领域

  • 水分缺乏
  • 蒸发性

依最终使用者

  • 医院
  • 眼科中心
  • 门诊手术中心
  • 其他

依地区

  • 北美
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东和非洲

目录

第一章 摘要整理

第二章：市场概览

  • 市场定义与市场区隔
  • 市场动态
  • 价值链分析
  • 新冠疫情影响分析
  • 波特五力分析
  • 俄乌衝突的影响
  • PESTLE 分析
  • 监理分析
  • 价格趋势分析

第三章 全球干眼症治疗设备市场展望，2019-2032

  • 全球干眼症治疗设备市场展望，依类型和价值（百万美元），2019-2032
    • 睑板腺疏通设备
    • 点状阻塞设备
    • 止痛设备
    • 其他
  • 全球干眼症治疗设备市场展望，依病因和价值（百万美元）， 2019-2032
    • 特发性
    • 罕见疾病
    • 手术
    • 药物相关
    • 数位暴露
    • 年龄相关
  • 全球干眼治疗设备市场展望（依应用领域划分，收入（百万美元）），2019-2032
    • 水分不足
    • 汽化性
  • 干眼治疗设备市场展望（以最终用户划分，收入（百万美元）），2019-2032
    • 医院
    • 眼科中心
    • 门诊手术中心
    • 其他
  • 全球干眼治疗设备市场展望（依地区划分，收入（百万美元）），2019-2032
    • 北美
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲

第四章：北美干眼症设备市场展望（2019-2032）

第五章：欧洲干眼症设备市场展望（2019-2032）

第六章：亚太地区干眼症设备市场展望（2019-2032）

第七章：拉丁美洲干眼症设备市场展望（2019-2032）

第八章：中东与非洲干眼症设备市场展望（2019-2032）

第九章：竞争格局

  • 公司与区隔市场热力图
  • 公司市占率分析（2024）
  • 竞争对手仪錶板
  • 公司简介
    • 爱尔康视觉有限公司
    • 强生服务公司
    • 艾伯维公司
    • Lumenis Be Ltd
    • ESW - Vision
    • MiBo Medical Group
    • Sight Sciences
    • Eyedetec Medical Inc.
    • BlephEx
    • NuSight Medicals- NuLids LLC

第十章附录

简介目录

The global Dry Eye Disease Treatment Devices Market is witnessing robust growth as the burden of dry eye continues to rise across age groups and geographies. With increasing screen dependency, lifestyle transitions, and expanding awareness of ocular health, demand for advanced treatment technologies is accelerating rapidly. The market is valued at USD 260 million in 2025 and is projected to reach USD 430 million by 2032, registering a CAGR of 7.5%. The shift from traditional treatment approaches to device-based therapeutic care is strengthening the industry's long-term growth outlook.

Market Insights

Dry Eye Disease (DED) has evolved into one of the most commonly diagnosed ophthalmic conditions globally, impacting quality of life and visual performance. As clinicians seek more effective interventions, device-based therapies are gaining momentum due to their non-invasive nature, faster relief outcomes, and ability to address underlying gland dysfunction rather than only providing symptomatic improvement.

Technological advancements such as thermal pulsation, targeted light-based therapy, automated meibomian gland treatment, and at-home maintenance devices continue to reshape the care continuum. Increasing awareness campaigns and growing willingness among patients to adopt premium therapeutic solutions are further supporting market expansion. Manufacturers are increasingly focusing on ergonomic design, portability, and improved treatment efficiency to meet rising clinical and at-home demand.

Market Drivers

A surge in digital device usage, particularly among younger populations, has become one of the most significant contributors to the growing incidence of dry eye. The rise in computer-centric work environments, increased smartphone dependence, and prolonged screen exposure contribute to blinking abnormalities and tear film instability. Combined with age-related changes, environmental factors, contact lens use, post-operative dryness, and medication-associated symptoms, the prevalence of the disease continues to escalate.

Innovation serves as a central driver, with modern devices offering targeted therapeutic action on meibomian gland obstructions and tear drainage pathways. Improved diagnostic capabilities are enabling early detection, thus expanding treatment opportunities. Growing healthcare expenditure, rising patient awareness, and greater clinical preference for integrated technology-based solutions support sustained demand. Favorable regulatory approvals and broader product availability further contribute to market expansion.

Business Opportunity

The global market offers considerable opportunities across both clinical and home-care settings. Compact and user-friendly devices designed for daily maintenance are becoming increasingly popular, especially in developed markets where patients prefer long-term comfort solutions with minimal clinic visits. Companies focusing on cost-effective, hybrid therapy systems that combine heat, vibration, and mechanical stimulation are expected to gain substantial traction.

Integration with tele-ophthalmology, AI-driven eye diagnostics, and smart-monitoring platforms presents strong potential for future growth. Partnerships between manufacturers and large eye care chains are improving distribution efficiency and helping companies enhance brand visibility. Additionally, expanding penetration into emerging markets, where rising healthcare access is boosting ophthalmic device adoption, offers promising growth avenues.

Region Analysis

North America holds a major share in the global Dry Eye Disease Treatment Devices Market due to widespread awareness of dry eye conditions, high adoption of advanced therapeutic devices, and increased prevalence of digital eye strain. The region benefits from a strong network of eye care clinics, high purchasing power, and ongoing technological innovation.

Europe continues to show steady growth driven by a rising elderly population, increased access to specialty care, and rising preference for non-invasive therapeutic options. Regulatory support for advanced medical devices and strong demand for premium eye care technologies contribute to the region's expanding market presence.

Asia Pacific is expected to emerge as the fastest-growing regional market over the forecast period. Rapid urbanization, extensive screen exposure, and high rates of contact lens use are major contributors to rising dry eye prevalence. Countries such as China, India, Japan, and South Korea are witnessing rapid expansion in eye care infrastructure, creating significant opportunities for device manufacturers.

Latin America and the Middle East & Africa show growing potential supported by improving healthcare access, expanding private hospital networks, and increasing awareness about eye health and preventive care technologies.

Key Players

  • Alcon Vision LLC
  • Johnson and Johnson Services Inc
  • AbbVie Inc.
  • Lumenis Be Ltd
  • ESW - Vision
  • MiBo Medical Group
  • Sight Sciences
  • Eyedetec Medical Inc.
  • BlephEx
  • NuSight Medicals- NuLids LLC
  • Others

Global Dry Eye Disease Treatment Devices Market Segmentation

By Type

  • Meibomian Gland Unclogging Devices
  • Punctual Occlusion Devices
  • Pain-Reliving Devices
  • Others

By Cause

  • Idiopathic
  • Rare Diseases
  • Surgery
  • Drug Intake Associated
  • Digital Exposure
  • Age-Related

By Application

  • Aqueous Deficient
  • Evaporative

By End Users

  • Hospitals
  • Eye Care Centers
  • Ambulatory Surgical Centers
  • Others

By Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Dry Eye Disease Treatment Devices Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value, 2025
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. COVID-19 Impact Analysis
  • 2.5. Porter's Fiver Forces Analysis
  • 2.6. Impact of Russia-Ukraine Conflict
  • 2.7. PESTLE Analysis
  • 2.8. Regulatory Analysis
  • 2.9. Price Trend Analysis
    • 2.9.1. Current Prices and Future Projections, 2025-2032
    • 2.9.2. Price Impact Factors

3. Global Dry Eye Disease Treatment Devices Market Outlook, 2019-2032

  • 3.1. Global Dry Eye Disease Treatment Devices Market Outlook, by Type, Value (US$ Mn), 2019-2032
    • 3.1.1. Meibomian Gland Unclogging Devices
    • 3.1.2. Punctual Occlusion Devices
    • 3.1.3. Pain-Reliving Devices
    • 3.1.4. Others
  • 3.2. Global Dry Eye Disease Treatment Devices Market Outlook, by Cause, Value (US$ Mn), 2019-2032
    • 3.2.1. Idiopathic
    • 3.2.2. Rare Diseases
    • 3.2.3. Surgery
    • 3.2.4. Drug Intake Associated
    • 3.2.5. Digital Exposure
    • 3.2.6. Age-Related
  • 3.3. Global Dry Eye Disease Treatment Devices Market Outlook, by Application, Value (US$ Mn), 2019-2032
    • 3.3.1. Aqueous Deficient
    • 3.3.2. Evaporative
  • 3.4. Global Dry Eye Disease Treatment Devices Market Outlook, by End Users, Value (US$ Mn), 2019-2032
    • 3.4.1. Hospitals
    • 3.4.2. Eye Care Centers
    • 3.4.3. Ambulatory Surgical Centers
    • 3.4.4. Others
  • 3.5. Global Dry Eye Disease Treatment Devices Market Outlook, by Region, Value (US$ Mn), 2019-2032
    • 3.5.1. North America
    • 3.5.2. Europe
    • 3.5.3. Asia Pacific
    • 3.5.4. Latin America
    • 3.5.5. Middle East & Africa

4. North America Dry Eye Disease Treatment Devices Market Outlook, 2019-2032

  • 4.1. North America Dry Eye Disease Treatment Devices Market Outlook, by Type, Value (US$ Mn), 2019-2032
    • 4.1.1. Meibomian Gland Unclogging Devices
    • 4.1.2. Punctual Occlusion Devices
    • 4.1.3. Pain-Reliving Devices
    • 4.1.4. Others
  • 4.2. North America Dry Eye Disease Treatment Devices Market Outlook, by Cause, Value (US$ Mn), 2019-2032
    • 4.2.1. Idiopathic
    • 4.2.2. Rare Diseases
    • 4.2.3. Surgery
    • 4.2.4. Drug Intake Associated
    • 4.2.5. Digital Exposure
    • 4.2.6. Age-Related
  • 4.3. North America Dry Eye Disease Treatment Devices Market Outlook, by Application, Value (US$ Mn), 2019-2032
    • 4.3.1. Aqueous Deficient
    • 4.3.2. Evaporative
  • 4.4. North America Dry Eye Disease Treatment Devices Market Outlook, by End Users, Value (US$ Mn), 2019-2032
    • 4.4.1. Hospitals
    • 4.4.2. Eye Care Centers
    • 4.4.3. Ambulatory Surgical Centers
    • 4.4.4. Others
  • 4.5. North America Dry Eye Disease Treatment Devices Market Outlook, by Country, Value (US$ Mn), 2019-2032
    • 4.5.1. U.S. Dry Eye Disease Treatment Devices Market Outlook, by Type, 2019-2032
    • 4.5.2. U.S. Dry Eye Disease Treatment Devices Market Outlook, by Cause, 2019-2032
    • 4.5.3. U.S. Dry Eye Disease Treatment Devices Market Outlook, by Application, 2019-2032
    • 4.5.4. U.S. Dry Eye Disease Treatment Devices Market Outlook, by End Users, 2019-2032
    • 4.5.5. Canada Dry Eye Disease Treatment Devices Market Outlook, by Type, 2019-2032
    • 4.5.6. Canada Dry Eye Disease Treatment Devices Market Outlook, by Cause, 2019-2032
    • 4.5.7. Canada Dry Eye Disease Treatment Devices Market Outlook, by Application, 2019-2032
    • 4.5.8. Canada Dry Eye Disease Treatment Devices Market Outlook, by End Users, 2019-2032
  • 4.6. BPS Analysis/Market Attractiveness Analysis

5. Europe Dry Eye Disease Treatment Devices Market Outlook, 2019-2032

  • 5.1. Europe Dry Eye Disease Treatment Devices Market Outlook, by Type, Value (US$ Mn), 2019-2032
    • 5.1.1. Meibomian Gland Unclogging Devices
    • 5.1.2. Punctual Occlusion Devices
    • 5.1.3. Pain-Reliving Devices
    • 5.1.4. Others
  • 5.2. Europe Dry Eye Disease Treatment Devices Market Outlook, by Cause, Value (US$ Mn), 2019-2032
    • 5.2.1. Idiopathic
    • 5.2.2. Rare Diseases
    • 5.2.3. Surgery
    • 5.2.4. Drug Intake Associated
    • 5.2.5. Digital Exposure
    • 5.2.6. Age-Related
  • 5.3. Europe Dry Eye Disease Treatment Devices Market Outlook, by Application, Value (US$ Mn), 2019-2032
    • 5.3.1. Aqueous Deficient
    • 5.3.2. Evaporative
  • 5.4. Europe Dry Eye Disease Treatment Devices Market Outlook, by End Users, Value (US$ Mn), 2019-2032
    • 5.4.1. Hospitals
    • 5.4.2. Eye Care Centers
    • 5.4.3. Ambulatory Surgical Centers
    • 5.4.4. Others
  • 5.5. Europe Dry Eye Disease Treatment Devices Market Outlook, by Country, Value (US$ Mn), 2019-2032
    • 5.5.1. Germany Dry Eye Disease Treatment Devices Market Outlook, by Type, 2019-2032
    • 5.5.2. Germany Dry Eye Disease Treatment Devices Market Outlook, by Cause, 2019-2032
    • 5.5.3. Germany Dry Eye Disease Treatment Devices Market Outlook, by Application, 2019-2032
    • 5.5.4. Germany Dry Eye Disease Treatment Devices Market Outlook, by End Users, 2019-2032
    • 5.5.5. Italy Dry Eye Disease Treatment Devices Market Outlook, by Type, 2019-2032
    • 5.5.6. Italy Dry Eye Disease Treatment Devices Market Outlook, by Cause, 2019-2032
    • 5.5.7. Italy Dry Eye Disease Treatment Devices Market Outlook, by Application, 2019-2032
    • 5.5.8. Italy Dry Eye Disease Treatment Devices Market Outlook, by End Users, 2019-2032
    • 5.5.9. France Dry Eye Disease Treatment Devices Market Outlook, by Type, 2019-2032
    • 5.5.10. France Dry Eye Disease Treatment Devices Market Outlook, by Cause, 2019-2032
    • 5.5.11. France Dry Eye Disease Treatment Devices Market Outlook, by Application, 2019-2032
    • 5.5.12. France Dry Eye Disease Treatment Devices Market Outlook, by End Users, 2019-2032
    • 5.5.13. U.K. Dry Eye Disease Treatment Devices Market Outlook, by Type, 2019-2032
    • 5.5.14. U.K. Dry Eye Disease Treatment Devices Market Outlook, by Cause, 2019-2032
    • 5.5.15. U.K. Dry Eye Disease Treatment Devices Market Outlook, by Application, 2019-2032
    • 5.5.16. U.K. Dry Eye Disease Treatment Devices Market Outlook, by End Users, 2019-2032
    • 5.5.17. Spain Dry Eye Disease Treatment Devices Market Outlook, by Type, 2019-2032
    • 5.5.18. Spain Dry Eye Disease Treatment Devices Market Outlook, by Cause, 2019-2032
    • 5.5.19. Spain Dry Eye Disease Treatment Devices Market Outlook, by Application, 2019-2032
    • 5.5.20. Spain Dry Eye Disease Treatment Devices Market Outlook, by End Users, 2019-2032
    • 5.5.21. Russia Dry Eye Disease Treatment Devices Market Outlook, by Type, 2019-2032
    • 5.5.22. Russia Dry Eye Disease Treatment Devices Market Outlook, by Cause, 2019-2032
    • 5.5.23. Russia Dry Eye Disease Treatment Devices Market Outlook, by Application, 2019-2032
    • 5.5.24. Russia Dry Eye Disease Treatment Devices Market Outlook, by End Users, 2019-2032
    • 5.5.25. Rest of Europe Dry Eye Disease Treatment Devices Market Outlook, by Type, 2019-2032
    • 5.5.26. Rest of Europe Dry Eye Disease Treatment Devices Market Outlook, by Cause, 2019-2032
    • 5.5.27. Rest of Europe Dry Eye Disease Treatment Devices Market Outlook, by Application, 2019-2032
    • 5.5.28. Rest of Europe Dry Eye Disease Treatment Devices Market Outlook, by End Users, 2019-2032
  • 5.6. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Dry Eye Disease Treatment Devices Market Outlook, 2019-2032

  • 6.1. Asia Pacific Dry Eye Disease Treatment Devices Market Outlook, by Type, Value (US$ Mn), 2019-2032
    • 6.1.1. Meibomian Gland Unclogging Devices
    • 6.1.2. Punctual Occlusion Devices
    • 6.1.3. Pain-Reliving Devices
    • 6.1.4. Others
  • 6.2. Asia Pacific Dry Eye Disease Treatment Devices Market Outlook, by Cause, Value (US$ Mn), 2019-2032
    • 6.2.1. Idiopathic
    • 6.2.2. Rare Diseases
    • 6.2.3. Surgery
    • 6.2.4. Drug Intake Associated
    • 6.2.5. Digital Exposure
    • 6.2.6. Age-Related
  • 6.3. Asia Pacific Dry Eye Disease Treatment Devices Market Outlook, by Application, Value (US$ Mn), 2019-2032
    • 6.3.1. Aqueous Deficient
    • 6.3.2. Evaporative
  • 6.4. Asia Pacific Dry Eye Disease Treatment Devices Market Outlook, by End Users, Value (US$ Mn), 2019-2032
    • 6.4.1. Hospitals
    • 6.4.2. Eye Care Centers
    • 6.4.3. Ambulatory Surgical Centers
    • 6.4.4. Others
  • 6.5. Asia Pacific Dry Eye Disease Treatment Devices Market Outlook, by Country, Value (US$ Mn), 2019-2032
    • 6.5.1. China Dry Eye Disease Treatment Devices Market Outlook, by Type, 2019-2032
    • 6.5.2. China Dry Eye Disease Treatment Devices Market Outlook, by Cause, 2019-2032
    • 6.5.3. China Dry Eye Disease Treatment Devices Market Outlook, by Application, 2019-2032
    • 6.5.4. China Dry Eye Disease Treatment Devices Market Outlook, by End Users, 2019-2032
    • 6.5.5. Japan Dry Eye Disease Treatment Devices Market Outlook, by Type, 2019-2032
    • 6.5.6. Japan Dry Eye Disease Treatment Devices Market Outlook, by Cause, 2019-2032
    • 6.5.7. Japan Dry Eye Disease Treatment Devices Market Outlook, by Application, 2019-2032
    • 6.5.8. Japan Dry Eye Disease Treatment Devices Market Outlook, by End Users, 2019-2032
    • 6.5.9. South Korea Dry Eye Disease Treatment Devices Market Outlook, by Type, 2019-2032
    • 6.5.10. South Korea Dry Eye Disease Treatment Devices Market Outlook, by Cause, 2019-2032
    • 6.5.11. South Korea Dry Eye Disease Treatment Devices Market Outlook, by Application, 2019-2032
    • 6.5.12. South Korea Dry Eye Disease Treatment Devices Market Outlook, by End Users, 2019-2032
    • 6.5.13. India Dry Eye Disease Treatment Devices Market Outlook, by Type, 2019-2032
    • 6.5.14. India Dry Eye Disease Treatment Devices Market Outlook, by Cause, 2019-2032
    • 6.5.15. India Dry Eye Disease Treatment Devices Market Outlook, by Application, 2019-2032
    • 6.5.16. India Dry Eye Disease Treatment Devices Market Outlook, by End Users, 2019-2032
    • 6.5.17. Southeast Asia Dry Eye Disease Treatment Devices Market Outlook, by Type, 2019-2032
    • 6.5.18. Southeast Asia Dry Eye Disease Treatment Devices Market Outlook, by Cause, 2019-2032
    • 6.5.19. Southeast Asia Dry Eye Disease Treatment Devices Market Outlook, by Application, 2019-2032
    • 6.5.20. Southeast Asia Dry Eye Disease Treatment Devices Market Outlook, by End Users, 2019-2032
    • 6.5.21. Rest of SAO Dry Eye Disease Treatment Devices Market Outlook, by Type, 2019-2032
    • 6.5.22. Rest of SAO Dry Eye Disease Treatment Devices Market Outlook, by Cause, 2019-2032
    • 6.5.23. Rest of SAO Dry Eye Disease Treatment Devices Market Outlook, by Application, 2019-2032
    • 6.5.24. Rest of SAO Dry Eye Disease Treatment Devices Market Outlook, by End Users, 2019-2032
  • 6.6. BPS Analysis/Market Attractiveness Analysis

7. Latin America Dry Eye Disease Treatment Devices Market Outlook, 2019-2032

  • 7.1. Latin America Dry Eye Disease Treatment Devices Market Outlook, by Type, Value (US$ Mn), 2019-2032
    • 7.1.1. Meibomian Gland Unclogging Devices
    • 7.1.2. Punctual Occlusion Devices
    • 7.1.3. Pain-Reliving Devices
    • 7.1.4. Others
  • 7.2. Latin America Dry Eye Disease Treatment Devices Market Outlook, by Cause, Value (US$ Mn), 2019-2032
    • 7.2.1. Idiopathic
    • 7.2.2. Rare Diseases
    • 7.2.3. Surgery
    • 7.2.4. Drug Intake Associated
    • 7.2.5. Digital Exposure
    • 7.2.6. Age-Related
  • 7.3. Latin America Dry Eye Disease Treatment Devices Market Outlook, by Application, Value (US$ Mn), 2019-2032
    • 7.3.1. Aqueous Deficient
    • 7.3.2. Evaporative
  • 7.4. Latin America Dry Eye Disease Treatment Devices Market Outlook, by End Users, Value (US$ Mn), 2019-2032
    • 7.4.1. Hospitals
    • 7.4.2. Eye Care Centers
    • 7.4.3. Ambulatory Surgical Centers
    • 7.4.4. Others
  • 7.5. Latin America Dry Eye Disease Treatment Devices Market Outlook, by Country, Value (US$ Mn), 2019-2032
    • 7.5.1. Brazil Dry Eye Disease Treatment Devices Market Outlook, by Type, 2019-2032
    • 7.5.2. Brazil Dry Eye Disease Treatment Devices Market Outlook, by Cause, 2019-2032
    • 7.5.3. Brazil Dry Eye Disease Treatment Devices Market Outlook, by Application, 2019-2032
    • 7.5.4. Brazil Dry Eye Disease Treatment Devices Market Outlook, by End Users, 2019-2032
    • 7.5.5. Mexico Dry Eye Disease Treatment Devices Market Outlook, by Type, 2019-2032
    • 7.5.6. Mexico Dry Eye Disease Treatment Devices Market Outlook, by Cause, 2019-2032
    • 7.5.7. Mexico Dry Eye Disease Treatment Devices Market Outlook, by Application, 2019-2032
    • 7.5.8. Mexico Dry Eye Disease Treatment Devices Market Outlook, by End Users, 2019-2032
    • 7.5.9. Argentina Dry Eye Disease Treatment Devices Market Outlook, by Type, 2019-2032
    • 7.5.10. Argentina Dry Eye Disease Treatment Devices Market Outlook, by Cause, 2019-2032
    • 7.5.11. Argentina Dry Eye Disease Treatment Devices Market Outlook, by Application, 2019-2032
    • 7.5.12. Argentina Dry Eye Disease Treatment Devices Market Outlook, by End Users, 2019-2032
    • 7.5.13. Rest of LATAM Dry Eye Disease Treatment Devices Market Outlook, by Type, 2019-2032
    • 7.5.14. Rest of LATAM Dry Eye Disease Treatment Devices Market Outlook, by Cause, 2019-2032
    • 7.5.15. Rest of LATAM Dry Eye Disease Treatment Devices Market Outlook, by Application, 2019-2032
    • 7.5.16. Rest of LATAM Dry Eye Disease Treatment Devices Market Outlook, by End Users, 2019-2032
  • 7.6. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Dry Eye Disease Treatment Devices Market Outlook, 2019-2032

  • 8.1. Middle East & Africa Dry Eye Disease Treatment Devices Market Outlook, by Type, Value (US$ Mn), 2019-2032
    • 8.1.1. Meibomian Gland Unclogging Devices
    • 8.1.2. Punctual Occlusion Devices
    • 8.1.3. Pain-Reliving Devices
    • 8.1.4. Others
  • 8.2. Middle East & Africa Dry Eye Disease Treatment Devices Market Outlook, by Cause, Value (US$ Mn), 2019-2032
    • 8.2.1. Idiopathic
    • 8.2.2. Rare Diseases
    • 8.2.3. Surgery
    • 8.2.4. Drug Intake Associated
    • 8.2.5. Digital Exposure
    • 8.2.6. Age-Related
  • 8.3. Middle East & Africa Dry Eye Disease Treatment Devices Market Outlook, by Application, Value (US$ Mn), 2019-2032
    • 8.3.1. Aqueous Deficient
    • 8.3.2. Evaporative
  • 8.4. Middle East & Africa Dry Eye Disease Treatment Devices Market Outlook, by End Users, Value (US$ Mn), 2019-2032
    • 8.4.1. Hospitals
    • 8.4.2. Eye Care Centers
    • 8.4.3. Ambulatory Surgical Centers
    • 8.4.4. Others
  • 8.5. Middle East & Africa Dry Eye Disease Treatment Devices Market Outlook, by Country, Value (US$ Mn), 2019-2032
    • 8.5.1. GCC Dry Eye Disease Treatment Devices Market Outlook, by Type, 2019-2032
    • 8.5.2. GCC Dry Eye Disease Treatment Devices Market Outlook, by Cause, 2019-2032
    • 8.5.3. GCC Dry Eye Disease Treatment Devices Market Outlook, by Application, 2019-2032
    • 8.5.4. GCC Dry Eye Disease Treatment Devices Market Outlook, by End Users, 2019-2032
    • 8.5.5. South Africa Dry Eye Disease Treatment Devices Market Outlook, by Type, 2019-2032
    • 8.5.6. South Africa Dry Eye Disease Treatment Devices Market Outlook, by Cause, 2019-2032
    • 8.5.7. South Africa Dry Eye Disease Treatment Devices Market Outlook, by Application, 2019-2032
    • 8.5.8. South Africa Dry Eye Disease Treatment Devices Market Outlook, by End Users, 2019-2032
    • 8.5.9. Egypt Dry Eye Disease Treatment Devices Market Outlook, by Type, 2019-2032
    • 8.5.10. Egypt Dry Eye Disease Treatment Devices Market Outlook, by Cause, 2019-2032
    • 8.5.11. Egypt Dry Eye Disease Treatment Devices Market Outlook, by Application, 2019-2032
    • 8.5.12. Egypt Dry Eye Disease Treatment Devices Market Outlook, by End Users, 2019-2032
    • 8.5.13. Nigeria Dry Eye Disease Treatment Devices Market Outlook, by Type, 2019-2032
    • 8.5.14. Nigeria Dry Eye Disease Treatment Devices Market Outlook, by Cause, 2019-2032
    • 8.5.15. Nigeria Dry Eye Disease Treatment Devices Market Outlook, by Application, 2019-2032
    • 8.5.16. Nigeria Dry Eye Disease Treatment Devices Market Outlook, by End Users, 2019-2032
    • 8.5.17. Rest of Middle East Dry Eye Disease Treatment Devices Market Outlook, by Type, 2019-2032
    • 8.5.18. Rest of Middle East Dry Eye Disease Treatment Devices Market Outlook, by Cause, 2019-2032
    • 8.5.19. Rest of Middle East Dry Eye Disease Treatment Devices Market Outlook, by Application, 2019-2032
    • 8.5.20. Rest of Middle East Dry Eye Disease Treatment Devices Market Outlook, by End Users, 2019-2032
  • 8.6. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

  • 9.1. Company Vs Segment Heatmap
  • 9.2. Company Market Share Analysis, 2024
  • 9.3. Competitive Dashboard
  • 9.4. Company Profiles
    • 9.4.1. Alcon Vision LLC
      • 9.4.1.1. Company Overview
      • 9.4.1.2. Product Portfolio
      • 9.4.1.3. Financial Overview
      • 9.4.1.4. Business Strategies and Developments
    • 9.4.2. Johnson and Johnson Services Inc
      • 9.4.2.1. Company Overview
      • 9.4.2.2. Product Portfolio
      • 9.4.2.3. Financial Overview
      • 9.4.2.4. Business Strategies and Developments
    • 9.4.3. AbbVie Inc.
      • 9.4.3.1. Company Overview
      • 9.4.3.2. Product Portfolio
      • 9.4.3.3. Financial Overview
      • 9.4.3.4. Business Strategies and Developments
    • 9.4.4. Lumenis Be Ltd
      • 9.4.4.1. Company Overview
      • 9.4.4.2. Product Portfolio
      • 9.4.4.3. Financial Overview
      • 9.4.4.4. Business Strategies and Developments
    • 9.4.5. ESW - Vision
      • 9.4.5.1. Company Overview
      • 9.4.5.2. Product Portfolio
      • 9.4.5.3. Financial Overview
      • 9.4.5.4. Business Strategies and Developments
    • 9.4.6. MiBo Medical Group
      • 9.4.6.1. Company Overview
      • 9.4.6.2. Product Portfolio
      • 9.4.6.3. Financial Overview
      • 9.4.6.4. Business Strategies and Developments
    • 9.4.7. Sight Sciences
      • 9.4.7.1. Company Overview
      • 9.4.7.2. Product Portfolio
      • 9.4.7.3. Financial Overview
      • 9.4.7.4. Business Strategies and Developments
    • 9.4.8. Eyedetec Medical Inc.
      • 9.4.8.1. Company Overview
      • 9.4.8.2. Product Portfolio
      • 9.4.8.3. Financial Overview
      • 9.4.8.4. Business Strategies and Developments
    • 9.4.9. BlephEx
      • 9.4.9.1. Company Overview
      • 9.4.9.2. Product Portfolio
      • 9.4.9.3. Financial Overview
      • 9.4.9.4. Business Strategies and Developments
    • 9.4.10. NuSight Medicals- NuLids LLC
      • 9.4.10.1. Company Overview
      • 9.4.10.2. Product Portfolio
      • 9.4.10.3. Financial Overview
      • 9.4.10.4. Business Strategies and Developments

10. Appendix

  • 10.1. Research Methodology
  • 10.2. Report Assumptions
  • 10.3. Acronyms and Abbreviations